Day: August 24, 2022

Analysts say these ASX dividend shares are buys now

an older couple look happy as they sit at a laptop computer in their home.

an older couple look happy as they sit at a laptop computer in their home.

Are you looking for dividends shares to buy? If you are, then take a look at the two listed below which are rated as buys.

Here’s what you need to know about these growing dividend shares:

Dicker Data Ltd (ASX: DDR)

The first ASX dividend share that has been rated as a buy is leading technology hardware, software, and cloud distributor, Dicker Data.

It has been growing at a consistently solid rate for a decade and shows little sign of stopping any time soon. For example, during the first half of FY 2022, the company expects to report a 36% increase in revenue to $1,459 million and an 11% lift in operating profit before tax to a record of $51 million (excluding acquisition costs).

In response to this news, the team at Morgan Stanley retained their overweight rating with a trimmed price target of $14.00.

As for dividends, Morgan Stanley is forecasting fully franked dividends per share of 36.2 cents in FY 2022 and 42.2 cents in FY 2023. Based on the current Dicker Data share price of $11.68, this will mean yields of 3.1% and 3.6%, respectively.

Elders Ltd (ASX: ELD)

Another ASX dividend share that has been rated as a buy is Elders. It is a leading agribusiness company offering a range of services to rural and regional customers across the ANZ region.

After going through a very difficult period, the company has bounced back incredibly strongly in the last couple of years. This has seen the company report stellar earnings growth. This includes an 80% increase in first-half EBIT to $132.8 million last month.

The good news is that Goldman Sachs doesn’t believe that Elders’ growth is over and expects further growth in the near term. In addition, the broker likes the company due to its “strong track record; good industry structure; potential for positive earnings surprise; and an attractive valuation.”

Goldman Sachs currently has a buy rating and $21.00 price target on its shares.

In addition, it is forecasting dividends per share of 50 cents in FY 2022 and 53 cents in FY 2023. Based on the current Elders share price of $11.54, this implies attractive yields of 4.3% and 4.6%, respectively.

The post Analysts say these ASX dividend shares are buys now appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of August 4 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Dicker Data Limited. The Motley Fool Australia has positions in and has recommended Dicker Data Limited. The Motley Fool Australia has recommended Elders Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/a4NZtnW

Here are 3 ASX healthcare share results you might have missed

Three healthcare workers standing together and smiling.Three healthcare workers standing together and smiling.

The All Ordinaries Index (ASX: XAO) has been in a pendulum swing over the ASX reporting season. Here are three ASX healthcare companies that have gone under the radar.

Regis Healthcare Ltd (ASX: REG)

The Regis share price only lifted 0.32% to close at $1.59 after the company released its FY22 results today.

The ASX-listed residential care provider recorded a net loss after tax of $38.8 million. This is a major reversal of its net profit after tax (NPAT) of $19.9 million in FY21. It didn’t help that revenue only grew 3.4%.

One reason for the drop in Regis’ bottom line is likely the Australian government’s 2021-22 budget decision to remove Aged Care Approval Rounds. This means from 1 July 2024, consumers can choose an approved provider that best suits their needs. Consequently, the government will discontinue operational places/bed licenses from this date.

Given this discontinuation, the depreciation of the operational places needs to be adjusted from an indefinite period to the date of expiry, being 1 July 2024. The change brought about a $61 million negative impact on net profit.

However, this does not affect cash flow as Regis still declared a final dividend of 2.32 cents per share.

The dividend is 50% franked and payable on 30 September.

EBOS Group Limited (ASX: EBO)

The EBOS share price only increased 1.59% to close at $34.54 per share on Wednesday despite a strong set of FY22 results.

EBOS is a wholesaler and distributor of healthcare, medical and pharmaceutical products.

Revenue surged 16.6% to a record high of $10.7 billion due to strong performances from both the healthcare and animal care segments. Net profit after tax also rose from $202.6 million in FY21 to $228.2 million.

The healthcare distributor also declared a final dividend of NZ 49 cents per share, resulting in total dividends declared for FY22 to NZ 96 cents per share.

Despite the inflationary environment, the adverse impact of supply chain issues, and staff shortage, EBOS still managed to increase earnings before interest and taxation margin slightly in FY22.

Management emphasised the resilience of the business and expect another year of profitable growth in FY23. They believe the balance sheet is in sound shape to support expenditure needs as well as future growth opportunities.

Neuren Pharmaceuticals Ltd (ASX: NEU)

The Neuren share price went down slightly by 2.14% to $5.48 at the close of trade today on the back of company results for HY22.

Total revenue moved slightly from $234,000 to $283,000. Neuren’s net loss improved ever so slightly by 11% to $7 million.

Neuren is a biopharmaceutical company that engages in the development of new therapies for brain injury, neurodevelopment, and neurodegenerative disorders. So, it’s still spending money to develop commercial solutions.

The most notable development was in July when Neuren’s US partner Acadia Pharmaceuticals submitted an application to the US Food and Drug Administration (FDA) for trofinetide, a drug that could treat Rett syndrome in adults and pediatric patients aged two years and older.

While an application is promising, it’s still too early to know whether this will be a success or not. Such is the unpredictable nature of biotech companies.

The post Here are 3 ASX healthcare share results you might have missed appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of August 4 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor Raymond Jang has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/tZ5Ayrf

What boosted the Woodside share price on Wednesday?

An oil refinery worker stands in front of an oil rig with his arms crossed and a smile on his face as the Woodside share price climbs today

An oil refinery worker stands in front of an oil rig with his arms crossed and a smile on his face as the Woodside share price climbs todayThe Woodside Energy Group Ltd (ASX: WDS) share price went up more than 3%, adding to the ongoing rise over the last few weeks.

This gain compares to a 0.5% rise of the S&P/ASX 200 Index (ASX: XJO), so it was a day of useful outperformance for Woodside shareholders.

The oil and gas giant is highly sensitive to changes in the oil price. A higher commodity price means that Woodside can generate higher earnings for the same amount of resources produced.

According to CommSec, the oil price went up by around 4% overnight, so perhaps it is unsurprising that the Woodside share price rose by a similar amount.

Upcoming FY22 result

On 30 August, shareholders will receive the FY22 half-year result, revealing how much net profit after tax (NPAT) and cash flow the business generated. Investors will also learn how large the interim dividend is going to be.

Woodside has already given its 2022 second quarter report for the period ending 40 June 2022. In that, it revealed that it achieved an average realised price of $95 per barrel of oil equivalent. This helped it deliver revenue of $3.44 billion, a rise of 44% compared to the first quarter of 2022.

Construction starts on Pluto Train 2 project

The resources business announced today that construction has commenced on the Pluto Train 2 project, which it called a “key milestone supporting jobs and economic growth in Western Australia.”

This project will be the second liquefied natural gas (LNG) train at Woodside’s existing Pluto LNG onshore facility and will process gas from the Scarborough development. Pluto Train 2 will have an LNG capacity of around 5 million tonnes per annum. This boost could be helpful for the Woodside share price in the coming years.

Woodside said that, as the operator of Pluto Train 2 and Scarborough, it has made “commitments to the Western Australian Government in its community development plans to support positive and sustainable community outcomes in the Pilbara region.”

The CEO, Meg O’Neill, said that the gas processed through an expanded and efficient Pluto facility will “support the decarbonisation goals” of customers in Asia.

Bechtel will execute the engineering, procurement and construction of Pluto Train 2. It has already engaged a number of local and indigenous businesses to support delivery, with more awards anticipated as the project progresses.

Woodside share price snapshot

Over the past six months, Woodside shares have risen by 24.6%.

The post What boosted the Woodside share price on Wednesday? appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of August 4 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/tGVpACb

These three ASX 200 shares rocketed higher on earnings updates today

A woman jumps for joy with a rocket drawn on the wall behind her.A woman jumps for joy with a rocket drawn on the wall behind her.

The S&P/ASX 200 Index (ASX: XJO) climbed 0.52% today, but three ASX 200 shares soared even higher on financial results.

The Home Consortium (ASX: HMC), Iluka Resources Limited (ASX: ILU) and Netwealth Group Ltd (ASX: NWL) share prices all lifted today.

Let’s take a look at what led to these ASX 200 shares outperforming the index.

Iluka

ASX 200 mining share Iluka rose 9.84% today on half-yearly results. The company reported a nearly 186% boost in net profit in its H122 results. Iluka’s earnings before interest, tax, depreciation, and amortisation (EBITDA) also soared 70.5% to $525.5 million. Net total cash lifted to $600.3 million.

Iluka managing director Tom O’Leary said: “in a macroeconomic environment characterised by inflation and uncertainty, we increased margins and strengthened our balance sheet“.

In positive news for dividend investors, Iluka lifted its interim fully-franked dividend by 108.3% to 25 cents per share.

Netwealth

Netwealth shares soared 7.02% today. This follows the ASX 200 financial services share reporting a 2.7% lift in net profit to $55.6 million. Revenue lifted 19.6%, while operating expenses jumped 30.7%. Netwealth declared a fully franked final dividend of 10 cents per share. Total dividends for FY22 were 20 cents, 8% more than FY21. Netwealth is predicting inflows of $11 to $13 billion in FY23.

Home Consortium

The Home Consortium share price rocketed 10.85% today amid its FY22 full-year results. The company lifted its funds management revenues by 490% compared to FY21. External assets under management also exploded 321% to $5.8 billion.

Commenting on this result, CEO David Di Pilla said:

We strengthened the capital position of our funds through opportunistic asset sales which took advantage of the disconnect between property and global capital markets.

The ASX 200 property share said it is “well positioned” going into FY23 with strong momentum.

Home Consortium delivered a fully-franked FY22 dividend of 12 cents per share, the same as FY21.

The post These three ASX 200 shares rocketed higher on earnings updates today appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of August 4 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor Monica O’Shea has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Netwealth. The Motley Fool Australia has positions in and has recommended Netwealth. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/ohyeHYM